Sign in
4

Changes in Ownership

Roivant Sciences Ltd. Filed Acc 0001140361-25-046247

President & CIO sold 26,831 shares at $23.09 ($619,528)

  • President & CIO disposed of 32,682 shares (other)
  • President & CIO acquired 59,513 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Sukhatme Mayukh President & CIO 2025-12-17 Option exercise +59,513 $12.68 $754,625 18,896,060 D
Sukhatme Mayukh President & CIO 2025-12-17 Sale −26,831 $23.09 $619,528 18,869,229 D
Sukhatme Mayukh President & CIO 2025-12-17 Other disposition −32,682 $23.09 $754,627 18,836,547 D
Derivatives
Sukhatme Mayukh President & CIO 2025-12-17 Option exercise · Common Shares −59,513 1,304,198 D
Open-market sales · 26,831 sh · avg $23.09 · $619,528
Loading xslF345X05/form4.xml…